0 оценок0% нашли этот документ полезным (0 голосов)
231 просмотров4 страницы
Biocon Ranked at No 2 and Syngene at No 5
“Having forged strategic partnerships with the Mylan and BMS to consolidate its key insulin business, Biocon emerged even stronger in 2012” - Kiran Mazumdar-Shaw, Chairman and Managing Director
Biocon Ranked at No 2 and Syngene at No 5
“Having forged strategic partnerships with the Mylan and BMS to consolidate its key insulin business, Biocon emerged even stronger in 2012” - Kiran Mazumdar-Shaw, Chairman and Managing Director
Авторское право:
Attribution Non-Commercial (BY-NC)
Доступные форматы
Скачайте в формате PDF, TXT или читайте онлайн в Scribd
Biocon Ranked at No 2 and Syngene at No 5
“Having forged strategic partnerships with the Mylan and BMS to consolidate its key insulin business, Biocon emerged even stronger in 2012” - Kiran Mazumdar-Shaw, Chairman and Managing Director
Авторское право:
Attribution Non-Commercial (BY-NC)
Доступные форматы
Скачайте в формате PDF, TXT или читайте онлайн в Scribd